REVS: A new open-source platform for high-resolution analysis of rodent wheel running behavior
Journal of Neuroscience Methods · 2025
DOI: 10.1016/j.jneumeth.2025.110581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroscience Methods, 2025. Verfasst von James L Bonanno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT 06511, United States; Department of Neurology, Yale School of Medicine…. Hauptthemen laut MEDLINE: Software, Spinal Cord Injuries, Running, Motor Activity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Rodent wheel running is widely used in neuroscience and preclinical research to assess locomotor function, recovery post-trauma or disease, circadian rhythms, and exercise physiology. However, most existing wheel-running systems offer limited metrics, lack flexibility in hardware, or require costly proprietary software, reducing their usefulness for detailed behavioral phenotyping-especially in models of injury or rehabilitation. NEW METHOD: We developed REVS (Revolution Evaluation and Visualization Software), a low-cost, open-source hardware and software platform for analyzing and visualizing rodent wheel running behavior. REVS captures wheel revolutions using Hall effect sensors and computes 13 day-level behavioral metrics along with detailed bout-level data. Users can interactively explore high-resolution temporal features and export data in Open Data Commons (ODC)-compatible formats. REVS supports customizable wheel types, facilitating use in animals with motor and/or sensory impairments. RESULTS: We validated REVS using a mouse model of partial spinal cord injury, where fine motor control is compromised. REVS detected impairments in 10 of 13 behavioral metrics post-injury, with varied recovery trajectories across measures. Principal component analysis revealed that recovery was closely linked to bout quality and intensity, rather than timing. COMPARISON WITH EXISTING METHODS: Unlike commercial and open-source systems, REVS offers more detailed metrics, customizable wheel compatibility, seamless blending with common vivarium hardware, integrated data visualizations, and ODC-compatible data export. It also supports flexible analysis across individuals and groups. CONCLUSIONS: REVS provides a powerful, scalable tool for granular behavioral phenotyping in rodent studies, enhancing reproducibility and revealing insights into subtle locomotor changes associated with injury, recovery, and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT 06511, United States; Department of Neurology, Yale School of Medicine, New Haven, CT 06511, United States.
- Department of Neurology, Yale School of Medicine, New Haven, CT 06511, United States.
- Department of Neurology, Yale School of Medicine, New Haven, CT 06511, United States; Department of Neuroscience, Yale School of Medicine, New Haven, CT 06511, United States. Electronic address: william.cafferty@yale.ed…
Förderung
- NINDS NIH HHS
Zitieren
APA
Bonanno, J. L., O'Brien, C. F., & Cafferty, W. B. J. (2025). REVS: A new open-source platform for high-resolution analysis of rodent wheel running behavior. Journal of Neuroscience Methods. https://doi.org/10.1016/j.jneumeth.2025.110581
Vancouver
Bonanno JL, O'Brien CF, Cafferty WBJ. REVS: A new open-source platform for high-resolution analysis of rodent wheel running behavior. Journal of Neuroscience Methods. 2025. doi:10.1016/j.jneumeth.2025.110581
BibTeX
@article{Bonanno2025,
author = {Bonanno, James L and O'Brien, Ciara F and Cafferty, William B J},
title = {REVS: A new open-source platform for high-resolution analysis of rodent wheel running behavior},
journal = {Journal of Neuroscience Methods},
year = {2025},
doi = {10.1016/j.jneumeth.2025.110581}
}
EUVIMED